After the Autumn 2024 budget was announced by Chancellor of the Exchequer Rachel Reeves, MTI reached out to contacts in MedTech for comment on what it would mean for the industry, as well as being inundated with comments from the wider life sciences sector. Chris Whitehouse, Director of Health and MedTech Policy, Whitehouse Communications “Bucket-loads more money for the NHS, but conditional on reform and improved productivity – the best way to deliver which will be to make value based procurement a reality. Improving patient outcomes and experience, whilst saving substantial funds for the health and care system.
Wes Streeting needs to make it happen across the system.” Mark Leftwich, Managing Director, Philips UK & Ireland “The Chancellor's decision to increase capital investment in technology to deliver more NHS operations, scans and appointments shows early promise. Patients are stuck on waitlists, staff are facing burnout, and three quarters of NHS teams have faced a lack of investment in medical equipment and technological solutions.
This funding is a chance to start pulling the NHS back on track. “State-of-the-art technology is changing the way that care is delivered in pockets, but increased investment in digital and innovation is needed to accelerate this at scale. Primarily, we want to see this increase in capital investment come to life across facilities, infrastructure and innovation.
Focus should be on digitising NHS services, bringing the single patient.